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Alveolar bone destruction is a characteristic feature of periodontitis. Treponema denticola is known to be
involved in periodontitis. To elucidate the role of T. denticola in alveolar bone destruction in periodontitis, the
effects of lipooligosaccharide (LOS) from T. denticola on osteoclast formation and on expression of osteoclast
differentiation factor (ODF) and osteoprotegerin (OPG) mRNAs were examined in a coculture system by using
mouse calvaria and bone marrow cells. In addition, the effect of T. denticola LOS on expression of matrix
metalloproteinases (MMPs), which are involved in bone resorption, was estimated in mouse calvaria-derived
osteoblastic cells. When the mouse calvaria and bone marrow cells were challenged with LOS (0.1 to 10 g/ml)
for 4 days, the number of tartrate-resistant acid phosphatase-positive multinucleated cells increased in a
dose-dependent manner. The expression of ODF mRNA increased, while OPG mRNA expression decreased.
Polymyxin B changed the effect of LOS (10 g/ml) on ODF and OPG mRNA expression to the control level.
LOS (10 g/ml) stimulated prostaglandin E2 (PGE2) production in the cocultures. Adding indomethacin, an
inhibitor of prostaglandin synthesis, resulted in a reduction in the number of osteoclasts induced by LOS and
eliminated the effect of T. denticola LOS on ODF and OPG mRNA expression. T. denticola LOS increased the
levels of mRNAs encoding MMP-3, -8, -9, -10, -13, and -14. Expression of one of these mRNAs, MMP-9 mRNA,
was significantly induced by T. denticola LOS. These findings suggest that LOS from T. denticola stimulates
osteoclastogenesis and MMP expression. Up-regulation of ODF and down-regulation of OPG by a PGE2-
dependent mechanism were involved in the osteoclastogenesis induced by T. denticola LOS.
Osteoclasts are multinucleated cells with bone-resorbing ac-
tivity and play a crucial role in bone resorption. Osteoclast
formation requires the presence of osteoblast or stromal cells
(39). These cells express the osteoclast differentiation factor
(ODF) (also known as a receptor activator of the nuclear
factor-B [RANK] ligand) that promotes osteoclastogenesis
(21, 48). The osteoclast precursors that express RANK (the
receptor for ODF) recognize ODF through a cell-to-cell inter-
action with osteoblasts and differentiate into osteoclasts. Os-
teoprotegerin (OPG), which is also secreted by osteoblast lin-
eage cells, is a soluble decoy receptor that neutralizes the
biological activity of ODF (34, 42, 47). Osteoclastogenesis is
controlled by multiple factors, such as 1,25-dihydroxyvitamin
D3 [1,25(OH)2D3], parathyroid hormone (PTH), prostaglan-
din E2 (PGE2), and interleukin-1 (IL-1) (26, 38). The regula-
tion of ODF-OPG expression by these agents (1, 12–14, 25, 44,
47, 48) suggests that the effects of these factors on bone re-
sorption may be mediated through control of ODF and/or
OPG production and that osteoclast formation is determined
principally by the ratio of ODF to OPG. Therefore, a shift to
a higher ratio of ODF to OPG may be a major cause of bone
loss in many metabolic disorders, including osteoporosis and
periodontitis (15). Recently, it was reported that the ODF-
RANK interaction is not the sole pathway that causes oste-
oclast progenitors to differentiate into osteoclasts (19). Tumor
necrosis factor alpha (TNF-), which is involved in bone re-
sorption, can be substituted for the ODF to induce osteoclast
differentiation.
The matrix metalloproteinases (MMPs) are a family of
structurally and functionally related enzymes that are respon-
sible for the proteolytic degradation of the extracellular matrix
components. More than 20 different MMPs have been identi-
fied. These proteins can be classified into the following sub-
groups based on their substrate specificities and structural ho-
mologies: collagenase (MMP-1, -8, and -13), gelatinase
(MMP-2 and -9), stromelysin (MMP-3, -10, and -11), mem-
brane-type MMPs (MMP-14, -15, -16, -17, -23, -24, and -25),
and other MMPs, including matrilysin (MMP-7) and met-
alloelastase (MMP-12) (11, 22, 36). Previous reports suggested
that MMPs are involved in degrading the bone matrix. Various
MMPs, including MMP-2, -3, -9, -11, -12, -13, and -14, are
expressed in the osteoblasts. Bone resorption factors, such as
PTH, 1,25(OH)2D3, IL-1, IL-6, TNF-, and PGE2, regulate
the production of various MMPs in the osteoblasts (20, 40).
Furthermore, a nonselective MMP inhibitor neutralized bone
destruction stimulated by these bone resorption factors (20, 40,
41). This strongly suggests that the bone resorption factors
function at least in part through MMP induction. Bone resorp-
tion first requires the osteoblasts to release collagenase to
remove the nonmineralized organic matrix that covers the
bone surfaces. Osteoclasts are then chemotactically attracted
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to the resorption site, where they settle onto the calcified
matrix (2). Taken together, these reports suggest that the
MMPs may be important for the bone resorption process.
Periodontitis is an inflammatory disease, and loss of alveolar
bone is a hallmark of this disease (32). Treponema denticola is
one of the bacteria which have been implicated in the etiology
of periodontitis (6, 9, 35). This bacterium has multiple viru-
lence factors that include adhesins, proteolytic and hydrolytic
enzymes, cytopathic activity, and immunomodulation (3, 9).
For the virulence factor associated with bone resorption, it was
reported that the outer membrane of the bacterium increased
Ca2 release in an organ culture of fetal radii and ulnae (10).
Although this suggested that the heat-stable material of T.
denticola in the outer membrane might be involved in bone
resorption, the components of this bacterium which stimulate
bone resorption and the underlying mechanism have not been
studied. Recently, we reported that whole-cell sonicates of
Treponema lecithinolyticum associated with aggressive peri-
odontitis induced osteoclast formation (5). In this case, heat-
stable components were involved.
In this study, lipooligosaccharide (LOS) from T. denticola
was isolated, and its effects on osteoclastogenesis and on ex-
pression of both ODF and OPG mRNAs were investigated in
a coculture system consisting of mouse calvaria and bone mar-
row cells in order to determine the role of T. denticola in bone
resorption. In addition, regulation of the expression of several
MMPs by T. denticola LOS was estimated in mouse calvaria-
derived osteoblastic cells. This is the first report showing that
LOS from T. denticola induces osteoclast formation and that
this process is dependent on up-regulation of ODF expression
and down-regulation of OPG expression through PGE2 syn-
thesis. We also found that T. denticola LOS increased the
expression of the mRNAs of several MMPs in osteoblastic
cells.
MATERIALS AND METHODS
Materials. Mice (ICR strain) were obtained from Bio Korea Co. (Seoul,
Korea). The  minimum essential medium (-MEM), bovine serum albumin,
and heat-inactivated fetal bovine serum (FBS) were purchased from GIBCO
BRL (Grand Island, N.Y.). Indomethacin, polymyxin B, and a tartrate-resistant
acid phosphatase (TRAP) (a marker of osteoclasts) staining kit were obtained
from Sigma (St. Louis, Mo.).
Preparation of T. denticola sonicates. T. denticola ATCC 33521 was cultured
anaerobically in OMIZ-PAT broth for 3 to 5 days, as described previously (46).
The bacterial cells were harvested by centrifugation at 5,000  g for 10 min at
4°C. The cells were then washed three times with phosphate-buffered saline. The
bacterial cells were disrupted for 5 min with an ultrasonic processor (Sonic
Dismembrator; Fisher Scientific, Pittsburgh, Pa.) by using an output power of 8
W with 20-s intervals. The cell debris was removed after centrifugation at 15,000
 g for 5 min at 4°C, and the supernatant was collected. The protein concen-
trations were determined by using a Coomassie brilliant blue protein assay
reagent (Pierce, Rockford, Ill.).
Isolation of LOS. T. denticola LOS was isolated by the method described by
Walker et al. (45). The bacteria were cultured and harvested as described above.
The cell pellets were repeatedly frozen and thawed for 40 cycles and then
centrifuged at 6,000  g for 10 min to remove the cellular debris. The superna-
tant was centrifuged at 36,000  g for 30 min at 4°C, and the resulting pellet
containing the membrane fraction was washed twice in 60 ml of 0.05 M Tris-HCl
(pH 7.2) and suspended in Tris-HCl. The detergent-soluble outer membrane
fraction was obtained by extracting the membrane fraction with 1% Zwittergent
3.14 (Calbiochem Co., La Jolla, Calif.). To obtain the LOS, the detergent-soluble
fraction was digested with proteinase K (50 g/ml) at 37°C overnight. Two
volumes of 0.375 M MgCl2 in 95% ethanol (20°C) was added, and the prepa-
ration was kept at 20°C for 40 min and then centrifuged at 15,000  g for 20
min. The pellet was suspended in a solution containing 2% sodium dodecyl
sulfate, 0.1 M EDTA, and 10 mM Tris-HCl (pH 8.0). The proteinase K digestion-
ethanol precipitation procedure was repeated twice. The LOS was purified by
centrifugation at 48,000  g for 2 h at 4°C and suspended in a small volume of
distilled water. After the LOS was heated at 90°C for 30 min, it was quantified by
lyophilization, and the weight was measured. Sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (15% polyacrylamide gel) of the LOS was performed,
and the gels were silver stained.
Preparation of primary calvaria and bone marrow cells. The osteoblastic cells
were isolated from the calvariae of 1- to 2-day-old ICR mice as previously
described (5). The calvariae were digested in 10 ml of -MEM containing 0.2%
collagenase (Wako Pure Chemicals, Osaka, Japan) and 0.1% dispase (GIBCO
BRL) for 20 min at 37°C with vigorous shaking and then centrifuged at 1,500 
g for 5 min. The first supernatant was discarded, another 10 ml of the collage-
nase-dispase enzyme solution was added, and the preparation was incubated for
20 min. The digestion procedure was repeated four times, and the cells isolated
by the last three digestions were combined as an osteoblastic cell population.
They were cultured in -MEM containing 10% FBS and an antibiotic solution
(100 U of penicillin per ml, 100 g of streptomycin per ml, 25 g of amphotericin
B per ml) and used for the coculture system. The bone marrow cells were
collected from 5- to 8-week-old mice. The ends of the tibiae and femurs were
removed, and each marrow cavity was flushed by slowly injecting medium at one
end with a 25-gauge needle. The marrow cells were washed and used for the
coculture.
Osteoclast formation assay. The isolated calvaria cells were seeded at a con-
centration of 106 cells per 10-cm culture dish and grown to confluence. The cells
were then detached from the culture dishes with trypsin-EDTA (GIBCO BRL).
Subsequently, the cells (1  104 cells/well) were cocultured with the bone mar-
row cells (1  105 cells/well) in -MEM containing 10% FBS in 48-well plates
(Corning Inc., Corning, N.Y.). The culture volume was adjusted to 400 l per
well with -MEM containing 10% FBS. Either a bacterial sonicate or LOS was
added to each coculture with or without polymyxin B or indomethacin after the
medium was exchanged on day 3. The coculture was then maintained for an
additional 4 days. Osteoclast differentiation was monitored by using a TRAP
staining kit according to the manufacturer’s instructions. TRAP-positive
multinucleated cells having more than three nuclei per well were counted as
osteoclasts. ODF and OPG mRNA expression in the cocultures was determined
after the mRNA was isolated with TRIzol reagent (Life Technologies, Inc.,
Grand Island, N.Y.).
Osteoblastic cell cultures. To analyze expression of mRNAs of MMPs and
tissue inhibitors of metalloproteinases (TIMPs), osteoblastic cells isolated from
mouse calvariae were seeded into 24-well dishes at a density of 8  104 cells/well
in 800 l of -MEM containing 10% FBS. When the cells had grown to 80%
confluence, the medium was changed to -MEM containing 1 mg of bovine
serum albumin per ml. After incubation for 12 h, the cells were exposed to T.
denticola LOS alone or in combination with polymyxin B for 48 h. The mRNA
was isolated from the cultured osteoblastic cells by using TRIzol reagent accord-
ing to the manufacturer’s protocol (Life Technologies, Inc.).
RT-PCR. Expression of ODF, OPG, MMP, and TIMP mRNAs was deter-
mined by reverse transcription (RT)-PCR. Total RNA (1 g) from nontreated or
treated cells was used as a template for cDNA synthesis in a 20-l reaction
mixture performed with an RT kit (CLONTECH, Palo Alto, Calif.) used ac-
cording to the manufacturer’s instructions. The RNA (1 g) and oligo(dT)18
primers (1 mM) were denatured at 70°C for 5 min and incubated for 1 to 2 min
on ice. The denatured RNA and oligo(dT)18 primers were added to the reaction
mixture (1 U of Moloney murine leukemia virus reverse transcriptase per l, 1
reaction buffer, 500 M dATP, 500 M dCTP, 500 M dGTP, 500 M dTTP, 20
U of recombinant RNase inhibitor) and incubated at 42°C for 60 min, followed
by 94°C for 5 min.
The cDNA (4 l) was amplified by PCR in a 50-l reaction mixture containing
1 PCR buffer, each deoxynucleoside triphosphate at a concentration of 200
M, 200 pM forward primer, 200 pM reverse primer, and 0.5 U of Taq DNA
polymerase (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire,
United Kingdom) in a DNA thermal cycler (Biometra, Go¨ttingen, Germany).
The amplification reaction was performed for 35 cycles, and the primer se-
quences and annealing temperatures used are shown in Table 1. The PCR
products were separated by electrophoresis on a 1.5% agarose gel and visualized
by ethidium bromide staining. The relative intensities of the gel bands were
measured by using an image-analyzing program (TINA 2.0e; Neuro-Image Anal-
ysis Centre, Oxford, United Kingdom). In order to exclude contaminating DNA
from the isolated RNA, the RNA was subjected to PCR without cDNA synthesis.
In all preparations, no band was detected after PCR.
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PGE2 production assay. Osteoblastic cells (1  104 cells/well) were cocultured
with bone marrow cells (1  105 cells/well) in 200 l of -MEM containing 10%
FBS in 48-well plates (Corning Inc.). After the cells had grown to confluence, the
cocultures were treated with LOS (10 g/ml) in either the presence or the
absence of polymyxin B and incubated for an additional 24 h. PGE2 production
in the cocultures was determined by using a PGE2 enzyme immunoassay kit
according to the manufacturer’s instructions (Amersham Pharmacia Biotech).
Statistical analyses. The statistical significance of differences was determined
by the Mann-Whitney U test. A P value of 0.05 was considered significant.
RESULTS
Effect of T. denticola LOS on osteoclast formation in a co-
culture system. The purified lipopolysaccharide (LPS) prepa-
ration from T. denticola did not show a typical ladder-like band
pattern in sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis gels after staining with silver nitrate, as previously
described (28, 33). It migrated to a position between 7 and 14
kDa (based on the protein marker) and was not stained with
Coomassie brilliant blue (data not shown). These data mean
that the LPS preparation from T. denticola is LOS.
In the coculture treated with either the T. denticola sonicate
(10 g/ml) or LOS (0.1 to 10 g/ml) for 4 days, a number of
TRAP-positive multinucleated cells were formed, while the
nontreated cultures did not contain TRAP-positive multinu-
cleated cells. LOS increased the number of osteoclasts in a
dose-dependent manner (Fig. 1).
Effect of T. denticola LOS on expression of ODF and OPG
mRNAs. Expression of ODF and OPG mRNAs was investi-
gated with the cocultures treated with LOS for 4 days by
RT-PCR (Fig. 2). The nontreated cells exhibited steady-state
levels of ODF and OPG mRNA expression, as described in
other reports (16, 25). ODF mRNA expression increased and
OPG mRNA expression decreased after stimulation with T.
denticola LOS (0.1 to 10 g/ml). To confirm the effect of LOS
on ODF and OPG mRNA expression, an inhibition assay was
FIG. 1. Formation of TRAP-positive multinucleated cells in the
coculture system treated with whole-cell sonicates and LOS from T.
denticola. Mouse bone marrow and calvaria cells were cocultured to
confluence and treated with T. denticola sonicates (10 g/ml) or LOS
(0.1 to 10 g/ml) for an additional 4 days. The cells were then stained
for TRAP. The TRAP-positive multinucleated cells containing more
than three nuclei were counted as osteoclasts. The data are the means
 standard errors for four cultures. An asterisk indicates that the P
value is 0.05 for a comparison with the results for the nontreated
cultures.
TABLE 1. Sequences of primers for ODF, OPG, MMPs, TIMPs, and 	-actin
Molecule Direction Primer sequence Annealingtemp (°C)
Product
size
(bp)
ODF Forward 5
-ATCAGAAGACAGCACTCACT-3
 45.3 750
Reverse 5
-ATCTAGGACATCCATGCTAATGTTC-3

OPG Forward 5
-TGAGTGTGAGGAAGGGCGTTAC-3
 45.5 636
Reverse 5
-TTCCTCGTTCTCTCAATCTC-3

MMP-3 Forward 5
-GTACAGAGCTGTGGGAAGTCAATG-3
 60 287
Reverse 5
-ATCAGCTCCATAGTGTTGGAGTCC-3

MMP-7 Forward 5
-TGTTGATGGCAGCTATGCAGCTCA-3
 60 387
Reverse 5
-CTAAGTTCACTGGGATCTGCATAC-3

MMP-8 Forward 5
-TGACTCTGGTGATTTCTTGCTAA-3
 60 164
Reverse 5
-GTGAAGGTCAGGGGCGATGC-3

MMP-9 Forward 5
-CTGTCCAGACCAAGGGTACAGCCT-3
 60 263
Reverse 5
-GTGGTATAGTGGGACACATAGTGG-3

MMP-10 Forward 5
-GATGTACCCAGTCTACAGGTTCTC-3
 60 409
Reverse 5
-GTAGCCTGCTTGGACTTCATTTCC-3

MMP-11 Forward 5
-GGAGAAGACAGACCTCACCTATAG-3
 60 376
Reverse 5
-CTTAGCTGCTGTGGTGTGTTGTAG-3

MMP-12 Forward 5
-CCAGGAAATGCAGCAGTTCTTTGG-3
 60 252
Reverse 5
-CTTAGAGGAGTCACATCACTCCAG-3

MMP-13 Forward 5
-CATTCAGCTATCCTGGCCACCTTC-3
 60 250
Reverse 5
-CAAGTTTGCCAGTCACCTCTAAGC-3

MMP-14 Forward 5
-GAGATCAAGGCCAATGTTCGGAGG-3
 60 382
Reverse 5
-TTAGATCCTCATTTTGGACAGTCC-3

TIMP-1 Forward 5
-CCTTATACCAGCCGTTATAAGATCAAGAT-3
 60 346
Reverse 5
-GTCCACAAACAGTGAGTGTCACTC-3

TIMP-2 Forward 5
-GCAATGCAGACGTAGTGATCAGAG-3
 60 371
Reverse 5
-GATCATGGGACAGCGAGTGATCTT-3

	-Actin Forward 5
-GGACTCCTATGGTGGGTGACGAGG-3
 58 366
Reverse 5
-GGGAGAGCATAGCCCTCGTAGAT-3
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performed with polymyxin B, which is known to form a stable
complex with the lipid A of LPS and to neutralize LPS activity
(24). Polymyxin B (50 g/ml) eliminated the effect of LOS (10
g/ml) on ODF and OPG mRNA expression (Fig. 3).
Effect of indomethacin on osteoclast formation and expres-
sion of ODF and OPG mRNAs regulated by T. denticola LOS.
In order to determine whether PGE2 was involved in osteoclas-
togenesis induced by T. denticola LOS, PGE2 production in the
coculture treated with LOS (10 g/ml) in the presence or
absence of polymyxin B was determined. A low level of PGE2
was detected in the untreated cultures, and the PGE2 concen-
tration was higher in the cultures treated with LOS. Polymyxin
B (50 g/ml) decreased the PGE2 production stimulated by
LOS (Fig. 4). To confirm the involvement of PGE2 in oste-
oclast formation and the expression of ODF and OPG
mRNAs, cocultures were treated with LOS in the presence or
absence of indomethacin, which is a prostaglandin inhibitor. In
the coculture treated simultaneously with indomethacin (1
M) and LOS (10 g/ml) for 4 days, the number of TRAP-
positive multinucleated cells was significantly less than the
numbers of such cells in the cultures treated with LOS alone
(Fig. 5A). The ODF mRNA was down-regulated and the OPG
mRNA was up-regulated by indomethacin (Fig. 5B and C).
Indomethacin alone did not affect osteoclast formation and the
expression of ODF and OPG mRNAs (data not shown).
Expression of mRNAs of MMPs and TIMPs of osteoblastic
cells treated with T. denticola LOS. MMPs, including MMP-3,
-7, -8, -9, -10, -12, -13, and -14, and TIMPs, including TIMP-1
and -2, were examined by RT-PCR to determine expression of
their mRNAs in the osteoblastic cells treated with T. denticola
LOS (10 g/ml) for 48 h (Fig. 6A and B). The MMP-3, -8, -9,
-10, -13, and -14 and TIMP-1and -2 mRNAs were expressed in
the untreated osteoblastic cells, whereas MMP-7 and -12
mRNA expression could not be detected in treated or un-
treated cells. T. denticola LOS (10 g/ml) increased the
MMP-3, -8, -9, -10, -13, and -14 mRNA levels. Of these,
MMP-9 mRNA expression was markedly enhanced by T. den-
ticola LOS. T. denticola LOS slightly decreased TIMP-2
mRNA expression, whereas it did not influence TIMP-1
mRNA expression. To confirm the effect of T. denticola LOS
on MMP expression, the levels of expression of MMP-9, whose
mRNA exhibited a marked change in expression, were com-
pared for cells treated with LOS (10 g/ml), with polymyxin B
(50 g/ml), and with LOS plus polymyxin B (Fig. 6C and D).
Polymyxin B (50 g/ml) increased MMP-9 expression to some
extent compared to the expression in the untreated cells. How-
ever, polymyxin B (50 g/ml) decreased the MMP-9 expression
stimulated by T. denticola LOS to the same level observed for
the cells treated with polymyxin B alone.
FIG. 2. ODF and OPG mRNA expression in cocultures treated
with T. denticola LOS. After the cocultures were treated with the LOS
from T. denticola (0.1 to 10 g/ml), as described in the text, the ODF,
OPG, and 	-actin mRNA levels were examined by RT-PCR (A).
Signals in the RT-PCR were quantified and normalized to 	-actin
mRNA expression by using an image analyzer (B). The experiments
were repeated three times, and similar results were obtained in all
experiments.
FIG. 3. Effect of polymyxin B on the ODF and OPG mRNAs
induced by T. denticola LOS. After cocultures were treated with LOS
(10 g/ml) in the presence or absence of 10 g of polymyxin B per ml
(Poly10) or 50 g of polymyxin B per ml (Poly50) for 4 days, the ODF,
OPG, and 	-actin mRNA levels were examined by RT-PCR (A). The
signals in the RT-PCR were quantified and normalized to 	-actin
mRNA expression by using an image analyzer (B). The experiments
were repeated three times, and similar results were obtained in all
experiments.
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DISCUSSION
To determine the role of T. denticola in bone resorption, the
effects of T. denticola sonicates and LOS on osteoclast forma-
tion and MMP expression were examined. Osteoblasts or stro-
mal cells play an essential role in osteoclastogenesis through
ODF expression (48). Therefore, to investigate the effect of T.
denticola on osteoclastogenesis, a coculture system consisting
of mouse calvaria cells which contained primary osteoblasts
and bone marrow cells which included osteoclast precursors
was used. In the preliminary study, T. denticola sonicates stim-
ulated osteoclastogenesis in the coculture. This result
prompted us to search for a component of T. denticola involved
in osteoclastogenesis.
Yotis et al. (49) reported that T. denticola possesses an
LPS-like molecule (8 to 14 kDa) that exhibits Limulus amoe-
bocyte lysate clotting activity. Other research groups (28, 33)
purified an approximately 14- to 21-kDa LOS from T. denti-
cola. This LOS stimulated nitric oxide and TNF- production
in mouse macrophages, and the induction was inhibited by
polymyxin B (28). In addition, Schultz et al. (31) reported that
T. denticola LOS is quite different from the LPS of other
gram-negative bacteria. Therefore, it was of interest to inves-
tigate the ability of T. denticola LOS to stimulate osteoclasto-
genesis. Gopalsami et al. (10) reported that the outer mem-
brane of T. denticola increased Ca2 release in an organ
culture of radii and ulnae, and heat treating the outer mem-
brane did not alter the effect on Ca2 release. These authors
concluded that a heat-stable LPS-like material is present in the
outer membrane of T. denticola, which might be responsible
for bone resorption. Taken together, these findings imply that
the LOS from T. denticola may be involved in osteoclastogen-
esis. In the present study, T. denticola LOS was shown to
stimulate osteoclast differentiation in a dose-dependent man-
ner by using a coculture of osteoblast and osteoclast precur-
sors. This means that T. denticola LOS induces osteoclastogen-
esis. However, T. denticola sonicates induced more TRAP-
positive cells than LOS induced. In addition, when T. denticola
sonicates were heat treated, the osteoclast formation activity of
sonicates was not completely inhibited (data not shown).
Therefore, the possibility that some heat-labile components of
T. denticola are involved in osteoclastogenesis cannot be ruled
out.
It was reported previously that the osteoblast or stromal cell
FIG. 4. Effect of LOS on PGE2 production in cocultures. The co-
cultures were treated with LOS (10 g/ml) with or without polymyxin
B (Poly) (50 g/ml) for 24 h. The PGE2 concentration was determined
by using a PGE2 enzyme immunoassay kit. The data are the means 
standard errors for three cultures. One asterisk indicates that the P
value is 0.05 for a comparison with the results for the nontreated
cultures. Two asterisks indicate that the P value is 0.05 for a com-
parison with the results for the LOS-treated cultures.
FIG. 5. Effect of indomethacin on osteoclastogenesis and the ex-
pression of ODF and OPG mRNAs modulated by T. denticola LOS.
Cocultures were simultaneously treated with LOS (10 g/ml) with or
without indomethacin (Ind) (1 M) for 4 days. The cells were then
stained for TRAP to count the number of osteoclasts. The data are
means standard errors for three cultures (A). The RNA was isolated
from the cultured cells, and the ODF, OPG, and 	-actin mRNA levels
were analyzed by RT-PCR (B). The RT-PCR signals shown were
quantified and normalized to the 	-actin mRNA expression by using
an image analyzer (C). Representative results of three experiments
that yielded similar results are shown. An asterisk indicates that the P
value is 0.05 for a comparison with the results for the LOS-treated
cultures.
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lines that support osteoclastogenesis showed a much higher
ODF mRNA level, whereas the level of OPG mRNA was
drastically reduced in the presence of either PGE2 or
1,25(OH)2D3 (25). Another group of workers also reported
that 1,25(OH)2D3, PTH, or IL-11 prompted an increase in
the ratio of ODF to OPG (16). These findings indicate that the
effects of these bone resorptive factors are mediated through
regulation of the production of ODF and its endogenous re-
ceptor antagonist, OPG, and that the ODF/OPG ratio appears
to be an essential factor that determines the ability of osteo-
blastic cells to induce osteoclast formation. Since the discovery
of ODF, it has been believed that ODF is the sole factor
responsible for inducing osteoclast differentiation. However, it
has been shown that TNF- stimulates osteoclast formation via
an ODF-independent mechanism (19). Our results suggest
that the stimulatory effect of T. denticola LOS on osteoclast
formation is mediated through ODF up-regulation and OPG
down-regulation.
PGE2 has been shown to play a role in osteoclastogenesis
(17). Two studies on the involvement of PGE2 in ODF and
OPG mRNA expression in osteoblastic cells by LPS from
Escherichia coli had different results. Kikuchi et al. (18) re-
ported that LPS increased the ODF mRNA level and that an
inhibitor of PGE2 synthesis failed to block the effect of LPS
after 2 h of exposure, while OPG gene expression remained
constant after LPS stimulation. These authors suggested that
LPS induced ODF mRNA in osteoblasts directly, not via
PGE2, and did not affect OPG expression. In contrast, Sakuma
et al. (30) observed the effect of LPS for a longer period (24 h).
They showed that LPS exposure induced ODF mRNA expres-
sion in a time-dependent manner. Induction for 4 h was not
inhibited by indomethacin. However, induction for 24 h was
partially inhibited by indomethacin. Furthermore, LPS expo-
sure increased OPG mRNA expression, but the OPG levels
that were induced by LPS exposure were not affected by indo-
methacin. This report suggested that ODF is induced by LPS in
a PGE2-dependent manner and in a PGE2-independent man-
ner and that OPG expression by LPS is increased independent
of PGE2. To determine if PGE2 is involved in the effect that T.
denticola LOS has on ODF and OPG mRNA expression, we
estimated the numbers of osteoclasts and the levels of ODF
and OPG mRNA expression in cocultures treated with LOS in
the presence and in the absence of indomethacin for 4 days. T.
denticola LOS stimulated PGE2 production and osteoclast for-
FIG. 6. Expression of MMP and TIMP mRNAs in mouse calvaria-derived osteoblastic cells treated with T. denticola LOS. After the
osteoblastic cells were treated with T. denticola LOS (10 g/ml) in the absence (A) or in the presence (C) of polymyxin B (Poly) (50 g/ml) for
48 h, the RNA was isolated from the cells, and the MMP and TIMP mRNA levels were analyzed by RT-PCR. Representative results of three
experiments that yielded similar results are shown. The RT-PCR signals shown in panels A and C were quantified and normalized to 	-actin
mRNA expression by using an image analyzer (B and D).
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mation by LOS was reduced by indomethacin in coculture,
which suggests the possibility that PGE2 is involved in LOS-
regulated ODF and OPG expression. Like LPS, T. denticola
LOS increased ODF mRNA expression, and this stimulating
activity was inhibited by indomethacin. However, unlike regu-
lation by LPS, OPG mRNA was down-regulated by T. denticola
LOS, and the OPG mRNA level recovered to the control level
after treatment with indomethacin. Taken together, these find-
ings indicate that PGE2 is involved in the regulation of ODF
and OPG gene expression by T. denticola LOS. The down-
regulation of OPG gene expression by T. denticola LOS is
somewhat different from the results for LPS reported previ-
ously (18, 30). The discrepancy may result from the different
culture conditions used (i.e., the cell type and the stimulation
time) or from the structural differences between LPS and LOS.
It has been reported that PGE2 and IL-1 are involved in
osteoclast formation by Actinobacillus actinomycetemcomitans
LPS and that Porphyromonas gingivalis LPS promotes bone
resorption, which is mediated by IL-1, IL-6, TNF-, and PGE2
(4, 23, 43, 50). These previous studies suggest that cytokines,
such as IL-1, TNF-, and IL-6, are also involved in LPS-
induced osteoclastogenesis. We are currently studying the in-
volvement of proinflammatory cytokines in osteoclastogenesis
by T. denticola LOS.
The bone matrix consists of various proteins, including col-
lagen, proteoglycans, and glycoproteins (27, 29). Recent ob-
servations show that MMPs may play a role not only in dis-
solving the bone matrix but also in initiating bone resorption,
which determines where and when bone resorption occurs.
Removing nonmineralized matrix from the bone surface is
essential for initiating osteoclastic bone resorption, because
osteoclasts cannot attach to nonmineralized osteoid (2). In
order to determine the involvement of MMPs in bone resorp-
tion by T. denticola LOS, we analyzed the expression of mRNAs
of various MMPs. The most apparent increase was observed
for MMP-9. MMP-9 has broad substrate specificity, including
proteoglycans, glycoproteins, and gelatin, a denatured form of
collagen (22). In addition to gelatinase activity, MMP-9 exerts
chemotactic activity on osteoclasts. MMP-9 releases extracel-
lular matrix-bound vascular endothelial growth factor, which
acts as a chemoattractant for osteoclasts (8). TNF- is a bone
resorption-inducing factor, and it has been reported that the
proteolytic processing of this factor from its precursor to an
active form is carried out by MMP-9 (22). These reports imply
that MMP-9 may play an important role in the bone resorption
process by dissolving the bone matrix, releasing the chemotac-
tic factor on osteoclasts, and activating the cytokines involved
in bone resorption. Although the expression of mRNAs of
MMP-3, -8, -10, -13, and -14 is increased less than that of
mRNA of MMP-9 by T. denticola LOS in osteoblastic cells,
increased expression of the mRNAs of these MMPs was ob-
served in all three experiments. Therefore, in the future, the
significance of these MMPs in the bone resorption induced by
T. denticola LOS should be confirmed.
TIMPs are the major endogenous inhibitors that down-reg-
ulate MMP activity (7). Four TIMPs have been identified.
Although each TIMP inhibits most of the MMPs, a certain
degree of specificity has been observed. TIMP-1 and -2 are
inhibitors of MMP-9. TIMP-1 preferentially binds MMP-9 and
inhibits its activity (7, 37). The balance between the activities of
the MMPs and the TIMPs is believed to determine the rate of
matrix degradation. T. denticola LOS did not affect TIMP-1
mRNA expression and slightly decreased TIMP-2 mRNA ex-
pression in osteoblastic cells. These observations imply that
TIMPs have a minor effect on MMP-9 activity.
In conclusion, here we provide evidence that the LOS from
T. denticola stimulates osteoclastogenesis and the expression of
several MMPs, including MMP-9, in osteoblastic cells. ODF
up-regulation and OPG down-regulation via PGE2 are in-
volved in osteoclastogenesis. T. denticola is known to be one of
the major putative pathogens of periodontitis, a polymicrobial
infection. Our results show that the pathogenesis induced by T.
denticola may be one of the mechanisms of bone destruction in
periodontitis.
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